The Impact of the Initial Phase of the COVID-19 Pandemic on Patients With Autoimmune Bullous Diseases
Description
Introduction The follow-up of patients with autoimmune bullous diseases (AIBDs) was temporarily interrupted during the initial phase of the COVID-19 pandemic due to restrictions in healthcare services, given the high contagiousness and rapid spread
